| Title | Approval of Product under Voucher: Rare Pediatric Disease Priority Review Voucher; Opzelura (ruxolitinib) |
| ToC Doc | Rare Pediatric Disease Priority Review Voucher; Opzelura (ruxolitinib) |
| Docket Number | 2024-20556 |
| Type | Notice |
| Subject | Approval of Product under Voucher: Rare Pediatric Disease Priority Review Voucher; Opzelura (ruxolitinib) |
| Publication Date | 2024-09-11 |
| Last Updated Date | 2024-09-10 08:15:47 -0400 |
| Last Public Inspection | 2024-09-10 |
| Filed At | 2024-09-10T08:45:00.000-04:00 |
| 2024-20556_PI.pdf (87706 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 2 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...